ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Dianthus Therapeutics, Inc. /DE/

Filed

July 14, 2020

Accession Number

0001387131-20-006396

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →